0

Close
 
Upcoming Allied Market Research
2023
Medical Engineered Material Market

Medical Engineered Material Market

by Type (Medical Plastics, Medical Foams, Medical Films, Medical Adhesives, Medical Elastomer) and by Application (Medical Devices, Medical Disposable, Medical Wearable, Advanced Woundcare): Global Opportunity Analysis and Industry Forecast, 2023-2032

MC : Advanced Materials
Report Code: A15842
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Medical Engineered Material Market

Request Now !

Medical engineered materials (MEM) are materials used in the manufacture of medical products and services such as devices, disposables, and so on. These materials are intended for use in the production, safety, and construction of medical equipment. These are high-value-added materials that always exceed typical materials, resulting in lighter goods, have broader service temperature ranges, with multipurpose use, or have better life-cycle performance.

Medical engineered materials are applicable in medical disposables, medical devices, advanced wound care, and medical wearable.

COVID-19 Impact Analysis

  • Due to the COVID-19, there has been an increase in demand for personal protective equipment (PPE) kits, masks, drapes, and gloves. Capacity shortages have compelled healthcare facilities to upgrade and extend their infrastructure to fulfill the needs of rising patient intake. PPE kits and masks are in high demand from all sectors of the medical industry, as well as from the general public.
  • Due to a scarcity of medical masks, goggles, gowns, aprons, gloves, respirators, doctors, nurses, and other frontline personnel were critically under-equipped to care for COVID-19 patients. Companies have been working hard to supply the necessary number of masks and other supplies for healthcare professionals. For example, in March 2020, Apple (US) gave 2 million masks to the US. Similarly, Microsoft has distributed 15,000 pairs of safety goggles, as well as medical hats, infrared thermometers, and protective suits to countries throughout the world.
  • During the pandemic, medical gadgets such as patient care systems, thermal scanners, and related equipment will increase at a greater rate than others. Ventilators are crucial tools in the fight against the coronavirus, which demands a faster supply of raw materials including plastics, adhesives, and elastomers, as well as proper and timely logistical support and regulatory permissions. Diagnostic instruments and gadgets, such as thermal scanners, which are used to detect and monitor medical disorders, are also in high demand due to their importance in determining disease beginnings.

Top Impacting Factors

Medical equipment and devices are utilized in a variety of procedures, surgical purposes, and diagnostic. These gadgets and equipment are made with medical-designed materials. Demographic trends, such as an aging population and novel disease strains, are boosting demand for engineered materials in medical equipment. Globally, the aging population has a considerable impact on product design and manufacturing. New materials, such as soft-touch thermoplastic elastomers (TPE), and methods, such as over-molding, are among the new advancements that are expected to boost demand for medical engineered materials. Some of the restraints on the medical engineered materials market include government control over medical device prices, varying regulations, and moment approval processes.

Governments control the costs of healthcare facilities to ensure that they are accessible to everybody. This price pressure exists at all points along the value chain. As a result, medical device manufacturers and raw material suppliers must keep costs under control. 

This diminishes these players profit margins while also reforming their costs. The international healthcare industry is highly regulated. Medical device approval authorities assess device safety and performance in a variety of ways and issue product clearance in a variety of time frames. Medical waste is defined as garbage containing infectious materials. Waste generated by healthcare facilities such as medical research centers, veterinary clinics, hospitals, and labs is included. Plastics account for a sizable portion of the medical waste generated. On mostly yet another side, the transition to disposables has expanded the usage of plastics, but it is also generating more plastic garbage. Some single-use devices can be reused after being reprocessed. Consequently, the fear of infected products caused by improperly disinfected products leads to their destruction. Although manufacturers have begun to recycle plastics, the waste remains a significant challenge for the medical engineered materials business.


Market Trends

  • The Asia-Pacific region is expected to be the fastest-growing market for medical engineered materials. The Asia-Pacific medical engineered materials market is being driven by a growing population, a higher need for improved healthcare establishments, and a growth in lifestyle-related disorders.
  • China is the region's largest market for medical engineered materials. Because of its large manufacturing base, China is also a key producer and consumer of medical engineered materials in the region. Aside from India, South Korea, China, and Japan are expected to rise rapidly.
  • Further, the rising inclusion of digitalization and other sophisticated technologies such as 3D printing for the manufacturing of medical equipment is responsible for the market's rapid expansion in this category.
  • Market players are adopting many strategies such as R&D activities, acquisitions, mergers, contracts, new product launches, agreements, and partnerships to expand their business.
  • Evonik introduced a new RESOMER composites product line in April 2018. These bioresorbable polymers improve application development and enhance speedier patient recovery.
  • SABIC debuted its Polycarbonate (PC) based on certified renewable feedstock in October 2019, offering SABIC and its clients a solution that has the potential to minimize CO2 emissions as well as the usage of fossil feedstock during production. The certified PC resin can be used in a variety of market categories, including automotive, consumer, electronics and electrical, building and construction, and healthcare.
  • BASF's fiscal year ends in June 2020. The business spent USD 10 billion to build a verbund facility in Zhanjiang, Guangdong. The factories will manufacture tailored plastics and thermoplastic polyurethane (TPU) to meet the growing demands of various development industries in southern China and beyond Asia.
  • Covestro plans to invest in a new construction line in Thailand to create polycarbonate films in October 2020. The company's position in Asia-Pacific is likely to improve as a result of this investment.

Key Benefits of the Report

  • This study presents the analytical depiction of the medical engineered material industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the medical engineered material market share.
  • The current market is quantitatively analyzed to highlight the medical engineered material market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed medical engineered material market analysis based on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Medical Engineered Material Market Report

  • Who are the leading market players active in the medical engineered material market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?

 Medical Engineered Material Market Report Highlights

Aspects Details
By Type
  • Medical Plastics
  • Medical Foams
  • Medical Films
  • Medical Adhesives
  • Medical Elastomer
By Application
  • Medical Devices
  • Medical Disposable
  • Medical Wearable
  • Advanced Woundcare
By Region
  • Asia-Pacific  (China, India, Japan, South Korea, Rest of Asia-Pacific)
  • North America  (United States, Canada, Mexico)
  • Europe  (Germany, United Kingdom, France, Italy, Rest of Europe)
  • LAMEA  (Saudi Arabia, South Africa, Brazil, Rest of LAMEA)
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: MEDICAL ENGINEERED MATERIAL MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Medical Plastics

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Medical Foams

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Medical Films

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Medical Adhesives

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Medical Elastomer

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: MEDICAL ENGINEERED MATERIAL MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Medical Devices

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Medical Disposable

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Medical Wearable

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Advanced Woundcare

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: MEDICAL ENGINEERED MATERIAL MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Type

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Medical Engineered Material Market

        • 6.2.5.1. Market Size and Forecast, By Type
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Medical Engineered Material Market

        • 6.2.6.1. Market Size and Forecast, By Type
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Medical Engineered Material Market

        • 6.2.7.1. Market Size and Forecast, By Type
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Type

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Medical Engineered Material Market

        • 6.3.5.1. Market Size and Forecast, By Type
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Medical Engineered Material Market

        • 6.3.6.1. Market Size and Forecast, By Type
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Medical Engineered Material Market

        • 6.3.7.1. Market Size and Forecast, By Type
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Medical Engineered Material Market

        • 6.3.8.1. Market Size and Forecast, By Type
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Medical Engineered Material Market

        • 6.3.9.1. Market Size and Forecast, By Type
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Medical Engineered Material Market

        • 6.3.10.1. Market Size and Forecast, By Type
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Medical Engineered Material Market

        • 6.3.11.1. Market Size and Forecast, By Type
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Type

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Medical Engineered Material Market

        • 6.4.5.1. Market Size and Forecast, By Type
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Medical Engineered Material Market

        • 6.4.6.1. Market Size and Forecast, By Type
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Medical Engineered Material Market

        • 6.4.7.1. Market Size and Forecast, By Type
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Medical Engineered Material Market

        • 6.4.8.1. Market Size and Forecast, By Type
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Medical Engineered Material Market

        • 6.4.9.1. Market Size and Forecast, By Type
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Medical Engineered Material Market

        • 6.4.10.1. Market Size and Forecast, By Type
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Medical Engineered Material Market

        • 6.4.11.1. Market Size and Forecast, By Type
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Medical Engineered Material Market

        • 6.4.12.1. Market Size and Forecast, By Type
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Medical Engineered Material Market

        • 6.4.13.1. Market Size and Forecast, By Type
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Type

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Medical Engineered Material Market

        • 6.5.5.1. Market Size and Forecast, By Type
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Medical Engineered Material Market

        • 6.5.6.1. Market Size and Forecast, By Type
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Medical Engineered Material Market

        • 6.5.7.1. Market Size and Forecast, By Type
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Medical Engineered Material Market

        • 6.5.8.1. Market Size and Forecast, By Type
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Medical Engineered Material Market

        • 6.5.9.1. Market Size and Forecast, By Type
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Medical Engineered Material Market

        • 6.5.10.1. Market Size and Forecast, By Type
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Company 1

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Company 2

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Company 3

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Company 4

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Company 5

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Company 6

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Company 7

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Company 8

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Company 9

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Company 10

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL PLASTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FOAMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FILMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ADHESIVES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ELASTOMER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DISPOSABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL WEARABLE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET FOR ADVANCED WOUNDCARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. U.S. MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. U.S. MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 18. CANADA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. CANADA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. MEXICO MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE MEDICAL ENGINEERED MATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. EUROPE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. FRANCE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. GERMANY MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. ITALY MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. ITALY MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. SPAIN MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. UK MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. UK MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. RUSSIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. REST OF EUROPE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. ASIA-PACIFIC MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. CHINA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. CHINA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. JAPAN MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. INDIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. INDIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. SOUTH KOREA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. AUSTRALIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. THAILAND MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 55. MALAYSIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. INDONESIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA MEDICAL ENGINEERED MATERIAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. LAMEA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. BRAZIL MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH AFRICA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SAUDI ARABIA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. UAE MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. UAE MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. ARGENTINA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA MEDICAL ENGINEERED MATERIAL, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. REST OF LAMEA MEDICAL ENGINEERED MATERIAL, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. COMPANY 1: KEY EXECUTIVES
  • TABLE 76. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 77. COMPANY 1: OPERATING SEGMENTS
  • TABLE 78. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 79. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 80. COMPANY 2: KEY EXECUTIVES
  • TABLE 81. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 82. COMPANY 2: OPERATING SEGMENTS
  • TABLE 83. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 84. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 85. COMPANY 3: KEY EXECUTIVES
  • TABLE 86. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 87. COMPANY 3: OPERATING SEGMENTS
  • TABLE 88. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 89. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 90. COMPANY 4: KEY EXECUTIVES
  • TABLE 91. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 92. COMPANY 4: OPERATING SEGMENTS
  • TABLE 93. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 94. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 95. COMPANY 5: KEY EXECUTIVES
  • TABLE 96. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 97. COMPANY 5: OPERATING SEGMENTS
  • TABLE 98. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 99. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 100. COMPANY 6: KEY EXECUTIVES
  • TABLE 101. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 102. COMPANY 6: OPERATING SEGMENTS
  • TABLE 103. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 104. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 105. COMPANY 7: KEY EXECUTIVES
  • TABLE 106. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 107. COMPANY 7: OPERATING SEGMENTS
  • TABLE 108. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 109. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. COMPANY 8: KEY EXECUTIVES
  • TABLE 111. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 112. COMPANY 8: OPERATING SEGMENTS
  • TABLE 113. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 114. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. COMPANY 9: KEY EXECUTIVES
  • TABLE 116. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 117. COMPANY 9: OPERATING SEGMENTS
  • TABLE 118. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 119. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. COMPANY 10: KEY EXECUTIVES
  • TABLE 121. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 122. COMPANY 10: OPERATING SEGMENTS
  • TABLE 123. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 124. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION
  • FIGURE 2. GLOBAL MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 3. SEGMENTATION MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 11. MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL PLASTICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FOAMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL FILMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ADHESIVES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL ELASTOMER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. MEDICAL ENGINEERED MATERIAL MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL DISPOSABLE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. MEDICAL ENGINEERED MATERIAL MARKET FOR MEDICAL WEARABLE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. MEDICAL ENGINEERED MATERIAL MARKET FOR ADVANCED WOUNDCARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: MEDICAL ENGINEERED MATERIAL MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Medical Engineered Material Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers